Daily as of 3 Nov 16:00 ET
- Price
- below both $2.18 vs 50 $2.78 / 200 $3.85
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 10 Jun 2026 · projected 28 bars out
CTMX | CytomX TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$2.18
-$0.05 (-2.24%)
CytomX Therapeutics (CTMX) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.
The 50 SMA has sat below the 200 on the daily since Jun 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits below the 50 and the 200; on the weekly it is between the two.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- between the two $2.34 vs 50 $3.90 / 200 $2.24
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 10 Nov 2025 · projected 13 bars out
4-hour as of 3 Nov 16:00 ET
- Price
- below both $2.18 vs 50 $2.41 / 200 $3.09
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 10 Apr 2026 bar 2 · projected 14 bars out · tested 2 bars
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 10 Jun 2026 | 💀Death steep | daily | 28 bars out | Not tested |
| 10 Apr 2026 | 💀Death | 4-hour | 14 bars out | 2 bar cross test |
| week of 10 Nov 2025 | 🟨Golden moderate | weekly | 13 bars out | Not tested |
| 2 Oct 2025 | 🟨Golden | 4-hour | 30 bars out | — |
| 12 Sep 2025 | 💀Death | 4-hour | 10 bars out | — |
About CTMX
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$8.5M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorHealthcare
Cap bandsmall